Laser flow cytometry as a tool for the advancement of clinical medicine

Biomedicine and Pharmacotherapy

Volumn 85, Issue , 2017, Pages 434-443

  Aebisher, David ^a   Bartusik, Dorota ^b   Tabarkiewicz, Jacek ^c  

^a Shorter University   (United States)

^b SOUTHERN POLYTECHNIC STATE UNIVERSITY   (United States)

^c UNIVERSITY OF RZESZÓW   (Poland)

Author keywords

Disease diagnosis; Flow cytometry; Laser; Pharmacotherapy; Treatment monitoring

Indexed keywords

DIFFERENTIATION ANTIGEN; FLUORESCENT DYE;

ANTIGEN EXPRESSION; BIOMEDICINE; CELL SURFACE; CELLULAR PARAMETERS; CLINICAL MEDICINE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FLOW CYTOMETER; FLOW CYTOMETRY; HUMAN; LASER FLOW CYTOMETRY; NONHUMAN; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; CELL SEPARATION; CHEMICAL STRUCTURE; CHEMISTRY; DIAGNOSTIC TEST; LASER; PROCEDURES;

CELL SEPARATION; DIAGNOSTIC TESTS, ROUTINE; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; LASERS; MOLECULAR STRUCTURE;

EID: 85008145208     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2016.11.048     Document Type: Review

References (127)

1. [1] Patterson, J.O., Swaffer, M., Filby, A., An imaging flow cytometry-based approach to analyse the fission yeast cell cycle in fixed cells. Methods 82 (2015), 74–84.
2. [2] Bendall1, S.C., Nolan, G.P., Roederer, M., Chattopadhyay, P.K., A deep profiler's guide to cytometry. Trends Immunol. 33:7 (2012), 323–380.
3. [3] Spyropoulos, B., 50 years LASERS: in vitro diagnostics, clinical applications and perspectives. Clin. Lab. 57:3–4 (2011), 131–142.
4. [4] Kitsos, C.M., Bhamidipati, P., Melnikova, I., Cash, E.P., McNulty, C., Furman, J., Cima, M.J., Levinson, D., Combination of automated high throughput platforms, flow cytometry, and hierarchical clustering to detect cell state. Cytometry A 71 (2007), 16–27.
5. [5] Patterson, J.O., Swaffer, M., Filby, A., An imaging flow cytometry-based approach to analyze the fission yeast cell cycle in fixed cells. Methods 82 (2015), 74–84.
6. [6] Perfetto, S.P., Roederer, M., Increased immunofluorescence sensitivity using 532 nm laser excitation. Cytometry A 71:2 (2007), 73–79.
7. [7] Morgan, E., Varro, R., Sepulveda, H., Ember, J.A., Apgar, J., Wilson, J., Lowe, L., Chen, R., Shivraj, L., Agadir, A., Campos, R., Ernst, D., Gaur, A., Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110:3 (2004), 252–266.
8. [8] Edwards, B.S., Yound, S.M., Saunders, M.J., Bologa, C., Oprea, T.I., Ye, R.D., Prossnitz, E.R., Graves, S.W., Sklar, L.A., High-throughput flow cytometry for drug discovery. Exp. Opin. Drug Discov. 2:5 (2007), 1–12.
9. [9] Qiu, P., Simonds, E.F., Sean, C., Bendall, S.C., Gibbs, K.C., Bruggner, R.V., Linderman, M.D., Sachs, K.S., Nolan, G.P., Plevritis, S.K., SK, Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE. Nat. Biotechnol. 29:10 (2011), 886–891.
10. [10] Telford, W., Kapoor, V., Jackson, J., Burgess, W., Buller, G., Hawley, T., Hawley, R., Violet laser diodes in flow cytometry: an update. Cytometry A 69 (2006), 1153–1160.
11. [11] Yu, D., Baird, M.A., Allen, J.R., Howe, E.S., Klassen, M.P., Reade, A., Makhijani, K., Song, Y., Liu, S., Murthy, Z., Zhang, S.-Q., Weiner, O.D., Kornberg, T.B., Nung, Y., Davidson, M.W., Shu, X., A naturally monomeric infrared fluorescent protein for protein labeling in vivo. Nat. Methods 12 (2015), 763–765.
12. [12] Tuchin, A.V., Tárnok, A., Zharov, V.P., In vivo flow cytometry: a horizon of opportunities. Cytometry A 79:10 (2011), 737–745.
13. [13] Riccardi, C., Nicoletti, I., Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat. Protoc. 1:3 (2006), 1458–1461.
14. [14] Hamel, W., Dazin, P., Israel, M.A., Adaptation of a simple flow cytometric assay to identify different stages during apoptosis. Cytometry 25:2 (1996), 173–181.
15. [15] Lecoeur, H., de Oliveira-Pinto, L.M., Gougeon, M.L., Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay. J. Immunol. Methods 265 (2002), 81–96.
16. [16] Gaforio, J.J., Serrano, M.J., Algarra, I., Ortega, E., Alvarez de Cienfuegos, G., Phagocytosis of apoptotic cells assessed by flow cytometry using 7-aminoactinomycin D. Cytometry 49 (2002), 8–11.
17. [17] Sack, U., Tárnok, A., Rothe, G., Cellular Diagnostics: Basic Principles, Methods and Clinical Applications of Flow Cytometry. 2009, Karger Medical and Scientific Publishers.
18. [18] Tuchin, V.V., Advanced Optical Flow Cytometry: Methods and Disease Diagnoses. 2011, John Wiley & Sons.
19. [19] McClatchey, K.D., Clinical Laboratory Medicine. 2002, Lippincott Williams & Wilkins.
20. [20] Radbruch, A., Flow Cytometry and Cell Sorting. 2013, Springer Science & Business Media.
21. [21] Hagenbeek, T.J., Spits, H., T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus. Leukemia 22:3 (2008), 608–619.
22. + T cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int. Immunol. 28:4 (2016), 163–171.
23. [23] Soon, G., Lee, S.Y., Wang, S., Aggressive MLL gene rearranged CD7+ CD56+ myeloid / natural killer cell precursor acute leukaemia with extramedullary relapse in the uterus and breast. Pathology 47:6 (2015), 588–591.
24. [24] Kim, E.H., Neldner, B., J. Gui, J., Craig, R.W., Suresh, M., Mcl-1 regulates effector and memory CD8 T-cell differentiation during acute viral infection. Virology 490 (2016), 75–82.
25. [25] Uehara, K., Ikehara, F., Tanabe, Y., Nakazato, I., Oshiro, M., Inamine, M., Kinjo, T., CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival. Diagn. Pathol. 11:1 (2016), 16–20.
26. [26] Stoczynska-Fidelus, E., Piaskowski, S., Pawlowska, R., Szybka, M., Peciak, J., Hulas-Bigoszewska, K., Winiecka-Klimek, M., Rieske, P., Genetic heterogeneity of RPMI-8402, a T-acute lymphoblastic leukemia cell line. Oncol. Lett. 11:1 (2016), 593–599.
27. [27] Pfluecke, C., Berndt, K., Wydra, S., Tarnowski, D., Barthel, P., Quick, S., Ulbrich, S., Christoph, M., Waessnig, N., Speiser, U., Wunderlich, C., Poitz, D.M., Strasser, R.H., Ibrahim, K., Atrial fibrillation is associated with high levels of monocyte-platelet-aggregates and increased CD11b expression in patients with aortic stenosis. Thromb. Haemost. 115:5 (2016), 993–1000.
28. [28] Nohara, S., Kato, K., Fujiwara, D., Sakuragi, N., Yanagihara, K., Iwanuma, Y., Kajiyama, Y., Aminopeptidase N (APN/CD13) as a target molecule for scirrhous gastric cancer. Clin. Res. Hepatol. Gastroenterol. 40:4 (2016), 494–503.
29. [29] Mehrvar, A., Rahiminejad, M.S., Hedayati Asl, A.A., Tashvighi, M., Faranoush, M., Alebouyeh, M., Kuchakzadeh, L., Ramyar, A., Sabery Nejad, J., Mehrvar, N., Features of childhood acute myeloid leukemia in Iran: a report from double center study. Acta Med. Iran. 53:12 (2015), 749–752.
30. [30] González-Domínguez, E., Domínguez-Soto, A., Nieto, C., Flores-Sevilla, J.L., Pacheco-Blanco, M., Campos-Peña, V., Meraz-Ríos, M.A., Vega, M.A., Corbí, A.L., Sánchez-Torres, C., Atypical activin a and IL-10 production impairs human CD16+ monocyte differentiation into anti-Inflammatory macrophages. J. Immunol. 196:3 (2016), 1327–1337.
31. + regulatory T cells. Oral Oncol. 53 (2016), 27–35.
32. [32] Peters, J.M., Qasim Ansari, M., Multiparameter flow cytometry in the diagnosis and management of acute leukemia. Arch. Pathol. Lab. Med. 135 (2011), 44–54.
33. [33] Laurenti, L., Innocenti, I., Autore, F., Sica, S., Efremov, D.G., New developments in the management of chronic lymphocytic leukemia: role of atumumab. Onco Targets Ther. 9 (2016), 421–429.
34. [34] Castillo, J.J., Treon, S.P., Davids, M.S., Inhibition of the bruton tyrosine kinase pathway in B-cell lymphoproliferative disorders. Cancer J. 22:1 (2016), 34–36.
35. [35] Rozovski, U., Hazan-Halevy, I., Barzilai, M., Keating, M.J., Estrov, Z., Metabolism pathways in chronic lymphocytic leukemia. Leuk. Lymphoma 8 (2015), 1–8.
36. [36] Fellmann, M., Buschor, P., Röthlisberger, S., Zellweger, F., Vogel, M., High affinity targeting of CD23 inhibits IgE synthesis in human B cells. Immun. Inflamm. Dis. 3:4 (2015), 339–349.
37. [37] Bozorgi, A., Khazaei, M., Khazaei, M.R., New findings on breast cancer stem cells: a review. J. Breast Cancer 18:4 (2015), 303–312.
38. + subset proliferation. Drug Des. Dev. Ther. 10 (2016), 443–453.
39. [39] Yamada, Y., Jang, J.H., De Meester, I., Baerts, L., Vliegen, G., Inci, I., Yoshino, I., Weder, W., Jungraithmayr, W.J., CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression. J. Heart Lung Transplant. 35:4 (2016), 508–517.
40. [40] Peng, Y., Cai, J., Yue, C., Qing, X., Primary hepatic Epstein-Barr virus-associated CD30-positive peripheral T-cell lymphoma of cytotoxic phenotype. Exp. Mol. Pathol. 100:1 (2016), 207–211.
41. +) submesothelial fibroblasts. J. Obstet. Gynaecol. Can. 38:1 (2016), 41–50.
42. [42] Burgler, S., Role of CD38 expression in diagnosis and pathogenesis of chronic lymphocytic leukemia and its potential as therapeutic target. Crit. Rev. Immunol. 35:5 (2015), 417–432.
43. [43] Subbarao, V., Phillips, J., Stouffer, G.A., Update on glycoprotein IIb/IIa inhibitors. IDrugs 1:6 (1998), 668–674.
44. [44] Jeong, J.M., Kim, J.W., Kim, D.H., Park, C.I., First molecular cloning and gene expression analysis of teleost CD42 (glycoprotein Ib beta chain) GPIb-IX-V subunit from rock bream, Oplegnathus fasciatus. Dev. Comp. Immunol. 49:2 (2015), 298–302.
45. + circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event. Int. J. Cardiol. 208 (2016), 147–149.
46. [46] Peters, M., Qasim Ansari, M., Multiparameter flow cytometry in the diagnosis and management of acute leukemia. Arch. Pathol. Lab. Med. 135 (2011), 44–54.
47. [47] Dal-Bianco, J.P., Aikawa, E., Bischoff, J., Guerrero, J.L., Hjortnaes, J., Beaudoin, J., Szymanski, C., Bartko, P.E., Seybolt, M.M., Handschumacher, M.D., Sullivan, S., Garcia, M.L., Mauskapf, A., Titus, J.S., Wylie-Sears, J., Irvin, W.S., Chaput, M., Messas, E., Hagège, A.A., Carpentier, A., Levine, R.A., Myocardial infarction alters adaptation of the tethered mitral valve. J. Am. Coll. Cardiol. 67:3 (2015), 275–287.
48. [48] Matt, P., Lindqvist, U., Kleinau, S., Elevated membrane and soluble CD64: a novel marker reflecting altered FcγR function and disease in early rheumatoid arthritis that can be regulated by anti-rheumatic treatment. PLoS One, 10(9), 2015, e0137474.
49. [49] Son, S.M., Han, H.S., An, J.Y., Choe, K.H., Lee, K.M., Lee, K.H., Kim, S.S., Lee, Y.M., Lee, H.C., Song, H.G., Lee, O.J., Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1. Pathology (Phila.) 47:2 (2015), 123–129.
50. [50] Gagez, A.L., Tuaillon, E., Cezar, R., Dartigeas, C., Mahé, B., Letestu, R., Maisonneuve, H., Gouilleux-Gruart, V., Bollore, K., Ferrant, E., Aurran, T., Feugier, P., Leprêtre, S., Cartron, G., Response to rituximab in B-CLL patients is adversely impacted by frequency of IL-10 competent B cells and FcγRIIIa polymorphism. A study of FCGCLL/WM and GOELAMS groups. Blood Cancer J., 6(1), 2016, e389.
51. [51] Palanca-Wessels, M.C., Czuczman, M., Salles, G., Assouline, S., Sehn, L.H., Flinn, I., Patel, M.R., Sangha, R., Hagenbeek, A., Advani, R., Tilly, H., Casasnovas, O., Press, O.W., Yalamanchili, S., Kahn, R., Dere, R.C., Lu, D., Jones, S., Jones, C., Chu, Y.W., Morschhauser, F., Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study. Lancet Oncol. 16:6 (2015), 704–715.
52. [52] Dige, A., Magnusson, M.K., Öhman, L., Hvas, C.L., Kelsen, J., Wick, M.J., Agnholt, J., Reduced numbers of mucosal DR(int) macrophages and increased numbers of CD103(+) dendritic cells during anti-TNF-α treatment in patients with Crohn's disease. Scand. J. Gastroenterol. 51:6 (2016), 692–699.
53. [53] Noronha, E.P., Andrade, F.G., Zampier, C., de Andrade, C.F., Terra-Granado, E., Pombo-de-Oliveira, M.S., Brazilian study group for childhood leukaemia. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia. Blood Cells Mol. Dis. 57 (2016), 74–80.
54. [54] Zhou, L., Liu, X., Wang, X., Sun, Z., Song, X.T., CD123 redirected multiple virus-specific T cells for acute myeloid leukemia. Leuk. Res. 41 (2016), 76–84.
55. [55] Smith, D., Stephenson, C., Percy, L., Lach, A., Chatters, S., Kempski, H., Yong, K., Cohort analysis of FISH testing of CD138(+) cells in relapsed multiple myeloma: implications for prognosis and choice of therapy. Br. J. Haematol. 171:5 (2015), 881–886.
56. [56] Lu J, J., Ashwani, N., Zhang, M., He, H., Lu, J., Wang, Y., Zhao, W., Cao L, L., Ji, Z., He, Y., Hunag, Y., Chen, R., Huren, S., Diagnosed as mixed-phenotype acute leukemia didn't benefit from the CCLG-2008 protocol, retrospective analysis from single center. Indian J. Hematol. Blood Transfus 31:1 (2015), 32–37.
57. [57] Ma, C., Liu, H., Li, W., Chen, H., Jin, S., Wang, J., Label-free monitoring of DNA methyltransferase activity based on terminal deoxynucleotidyl transferase using a thioflavin T probe. J. Mol. Cell. Probes 30:2 (2016), 118–121.
58. [58] Lambert, J.M., Mol. Pharmaceutics Antibody-drug conjugates (ADCs): magic bullets at last!. Mol. Pharm. 12:6 (2015), 1701–1702.
59. [59] Reichert, J.M., Antibodies to watch in 2013. MAbs 5:4 (2013), 513–517.
60. [60] Ecker, D.M., Jones, S.D., Levine, H.L., The therapeutic monoclonal antibody market. MAbs 7:1 (2015), 9–14.
61. [61] Marcucci, F., Bellone, M., Rumio, C., Corti, A., Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells. MAbs 5:1 (2013), 34–46.
62. [62] Christiansen, J., Rajasekaran, A.K., Biological impediments to monoclonal antibody-based cancer immunotherapy. Mol. Cancer Ther. 3 (2004), 1493–1501.
63. [63] Lambert, J.M., Drug-conjugated antibodies for the treatment of cancer. Br. J. Clin. Pharmacol. 76:2 (2015), 248–262.
64. [64] Reff, M., Braslawsky, G., Hanna, N., Future approaches for treating hematologic disease. Curr. Pharm. Biotechnol. 2:4 (2001), 369–382.
65. 1H MRI application. Med. Chem. Res. 24:4 (2015), 1365–1368.
66. [66] Ricart, A.D., Antibody drug conjugates of calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab ozogamicin. Clin. Cancer Res. 17 (2011), 6417–6427.
67. [67] Senter, P.D., Sievers, E.L., The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Nat. Biotechnol. 30 (2012), 631–637.
68. [68] Shen, B.-Q., Bumbaca, D., Saad, O., Yue, Q., Pastuskoas, C.V., Khojasteh, S.C., Tibbits, J., Kaur, S., Wang, B., Chu, Y.W., LoRusso, P.M., Girish, S., Catabolic fate and pharmacokinetic characterization of trastuzumab emtansine: an emphasis on preclinical and clinical catabolism. Curr. Drug Metab. 13 (2012), 901–910.
69. + multiple myeloma. Front. Biosci. (Landmark Ed.) 19 (2014), 163–170.
70. [70] Galanzha, E.I., Zharov, V., Circulating tumor cell detection and capture by photoacoustic flow cytometry in vivo and ex vivo. Cancers 5:4 (2013), 1691–1738.
71. [71] Alix-Panabières, C., Schwarzenbach, H., Pantel, K., Circulating tumor cells and circulating tumor DNA. Annu. Rev. Med. 63 (2012), 199–215.
72. [72] Galanzha, E.I., Shashkov, E.V., Tuchin, V.V., Zharov, V.P., In vivo multispectral multiparameter, photoacoustic lymph flow cytometry with natural cell focusing, label-free detection and multicolor nanoparticle probes. Cytometry A, 73, 2008, 884894.
73. [73] Kolb, T., Albert, S., Haug, M., Whyte, G., Optofluidic rotation of living cells for single-cell tomography. J. Biophoton. 3:8 (2015), 239–246.
74. [74] Gerstner, A.O.H., Laffers, W., Tarnok, A., Clinical applications of slide-based cytometry − an update. J. Biophoton. 2:8–9 (2009), 463–469.
75. [75] Jiang, X., Dausend, J., Hafner, M., Musyanovych, A., Röcker, C., Landfester, K., Mailänder, V., Ulrich Nienhaus, G., Specific effects of surface amines on polystyrene nanoparticles in their interactions with mesenchymal stem cells. Biomacromolecules 11:3 (2010), 748–753.
76. [76] Álvarez-Barrientos, A., Arroyo, J., Cantón, R., Nombela, C., Sánchez-Pérez, M., Applications of flow cytometry to clinical microbiology. Clin. Microbiol. Rev. 13:2 (2000), 167–195.
77. [77] Adams, G., Weiner, L., Monoclonal antibody therapy of cancer. Nat. Biotechnol. 23 (2005), 1147–1157.
78. [78] Awtar, K., Ganapath, R., Laser flow cytometry and cancer chemotherapy: detection of intracellular anthracyclines by flow cytometry. J. Histochem. Cytochem. 27:12 (1979), 1655–1656.
79. [79] Chaffer, C.L., Weinberg, R.A., A perspective on cancer cell metastasis. Science 331 (2011), 1559–1564.
80. [80] Zubris, K.A.V., Liu, R., Colby, A., Schulz, M.D., Colson, Y.L., Grinstaff, M.W., In Vitro activity of paclitaxel-loaded polymeric expansile nanoparticles in breast cancer cells. Biomacromolecules 14:6 (2013), 2074–2082.
81. [81] Srinivas, O., Larrieu, P., Duverger, E., Boccaccio, C., Bousser, M.-T., Monsigny, M., Fonteneau, J.-F., Jotereau, F., Roche, A.-C., Synthesis of glycocluster-tumor antigenic peptide conjugates for dendritic cell targeting. Bioconjugate Chem. 18:5 (2007), 1547–1554.
82. [82] Dewhirst, M.W., Cao, Y., Moeller, B., Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat. Rev. Cancer 8 (2008), 425–430.
83. [83] Chiang, H.C., Elledge, R., Larson, P.O., Jatoi, I., Li, R., Hu, Y., Effects of radiation therapy on breast epithelial cells in BRCA1/2 mutation carriers. Breast Cancer: Basic Clin. Res. 9 (2015), 25–29.
84. [84] Weiss, R., Spittler, A., Schmitz, G., Fischer, M.B., Weber, V., Thrombocyte adhesion and release of extracellular microvesicles correlate with surface morphology of adsorbent polymers for lipid apheresis. Biomacromolecules 15:7 (2014), 2648–2655.
85. [85] Spatola, B.N., Murray, J.A., Kagnoff, M., Kaukinen, K., Daugherty, P.S., Antibody repertoire profiling using bacterial display identifies reactivity signatures of celiac disease. Anal. Chem. 85:2 (2013), 1215–1222.
86. [86] Cao, W., Zhou, J., Wang, Y., Zhu, L., Synthesis and in vitro cancer cell targeting of folate-functionalized biodegradable amphiphilic dendrimer-like star polymers. Biomacromolecules 11:12 (2010), 3680–3687.
87. [87] Lynge, M.E., Ogaki, R., Overgård Laursen, A., Lovmand, J., Sutherland, D.S., Städler, B., Polydopamine/liposome coatings and their interaction with myoblast cells. ACS Appl. Mater. Interfaces 3:6 (2011), 2142–2147.
88. [88] Sulistio, A., Lowenthal, J., Blencowe, A., Bongiovanni, M.N., Ong, L., Gras, S.L., Zhang, X., Qiao, G.G., Folic acid conjugated amino acid-based star polymers for active targeting of cancer cells. Biomacromolecules 12:10 (2011), 3469–3477.
89. [89] Qiu, T., Chen, Y., Song, J., Fan, L.-J., Preparation of cross-linked: multilayer-coated fluorescent microspheres with functional groups on the surface for bioconjugation. ACS Appl. Mater. Interfaces 7:15 (2015), 8260–8267.
90. [90] Sharma, R., Shivpuri, S., Anand, A., Kulshreshtha, A., Ganguli, M., Insight into the role of physicochemical parameters in a novel series of amphipathic peptides for efficient DNA delivery. Mol. Pharm. 10:7 (2013), 2588–2600.
91. [91] Lozano, M.M., Starkel, C.D., Longo, M.L., Vesicles tethered to microbubbles by hybridized DNA oligonucleotides: flow cytometry analysis of this new drug delivery vehicle design. Langmuir 26:11 (2010), 8517–8524.
92. [92] Prevette, L.E., Mullen, D.G., Banaszak Holl, M.M., Polycation-induced cell membrane permeability does not enhance cellular uptake or expression efficiency of delivered DNA. Mol. Pharm. 7:3 (2010), 870–883.
93. [93] Peiris, T.H., García-Ojeda, M.E., Oviedo, N.J., Alternative flow cytometry strategies to analyze stem cells and cell death in planarians. Regeneration 3:2 (2016), 123–135.
94. [94] Blinks, J.R., Wier, W.V.G., Hess, P., Prendergast, P.G., Measurement of Ca: heterogeneity of lymphocytec calcium metaboconcentrations in living cells. Prog. Biophys. Mol. Biol. 40 (1982), 1–114.
95. [95] Tsien, R.Y., Pozzans, T., Rink, T.V., Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new intracellularly trapped fluorescent indicator. J. Cell Biol. 94 (1982), 325–334.
96. 2+ with fluoro-3. Cytometry 11 (1990), 923–927.
97. [97] Raja, A.M., Xu, S., Zhuo, S., Tai, D.C.S., Sun, W., So, P.T.C., Welsch, R.E., Chen, C.S., Yu, H., Differential remodeling of extracellular matrices by breast cancer initiating cells. J. Biophoton. 8:10 (2015), 804–815.
98. [98] Oli, M., Aptamer conjugated gold nanorods for targeted nanothermal radiation of Glioblastoma cancer cells. A novel selective targeted approach to cancer treatment. Young Sci. J. 3 (2010), 18–25.
99. [99] Rai, P., Mallidi, S., Zheng, X., Rahmanzadeh, R., Mir, Y., Elrington, S., Khurshid, A., Hasan, T., Development and applications of photo-triggered theranostic agents. Adv. Drug Deliv. Rev. 62 (2010), 1094–1124.
100. [100] Ion, R.M., Planner, A., Wiktorowicz, K., Frackowiak, D., The incorporation of various porphyrins into blood cells measured via flow cytometry, absorption and emission spectroscopy. Acta Biochem. Pol. 45 (1998), 833–845.
101. [101] Gollnick, S.O., Evans, S.S., Baumann, H., Owczarczak, B., Maier, P., Vaughan, L., Wang, W.C., Unger, E., Henderson, B.W., Role of cytokines in photodynamic therapy-induced local and systemic inflammation. Br. J. Cancer 88:11 (2003), 1772–1779.
102. [102] Wang, C., Cheng, L., Liu, Z., Upconversion nanoparticles for photodynamic therapy and other cancer therapeutics. Theranostics 3:5 (2013), 317–330.
103. [103] Dou, Q.Q., Peng Teng, C., Ye, E., Loh, X.J., Effective near-infrared photodynamic therapy assisted by upconversion nanoparticles conjugated with photosensitizers. Int. J. Nanomed. 10 (2015), 419–432.
104. [104] Idris, N.M., Gnanasammandhan, M.K., Zhang, J., Ho, P.C., Mahendran, R., Zhang, Y., In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers. Nat. Med. 18:10 (2012), 1580–1585.
105. [105] Cui, S., Yin, D., Chen, Y., Di, Y., Chen, H., Ma, Y., Achilefu, S., Gu, Y., In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct. ACS Nano 7:1 (2012), 676–688.
106. [106] Guo, H., Qian, H., Idris, N.M., Zhang, Y., Singlet oxygen-induced apoptosis of cancer cells using upconversion fluorescent nanoparticles as a carrier of photosensitizer. Nanomed.: NBM 6 (2010), 486–495.
107. [107] Lucky, S.S., Idris, N.M., Li, Z., Huang, K., Soo, K.C., Zhang, Y., Titania coated upconversion nanoparticles for near-infrared light triggered photodynamic therapy. ACS Nano 9:1 (2015), 191–205.
108. 2 photosensitizing nanoplatform: near-infrared light mediated in vivo photodynamic therapy via mitochondria-involved apoptosis pathway. ACS Nano 9:3 (2015), 2584–2599.
109. [109] Rai, M., Singh, S.K., Singh, A.K., Prasad, R., Koch, B., Mishra, K., Rai, B., Enhanced red upconversion emission, magnetoluminescent behavior, and bioimaging application of NaSc0. 75Er0. 02Yb0. 18Gd0. 05F4@ AuNPs nanoparticles. ACS Appl. Mater. Interfaces 7:28 (2015), 15339–15350.
110. [110] Yang, G., Yang, D., Yang, P., Lv, R., Li, C., Zhong, C., He, F., Gai, S., Lin, J., A Single 808 nm near-infrared light-mediated multiple imaging and photodynamic therapy based on titania coupled upconversion nanoparticles. Chem. Mater. 27 (2015), 7957–7968.
111. [111] Zhou, A., Wei, Y., Wu, B., Chen, Q., Xing, D., Pyropheophorbide A and c(RGDyK) comodified chitosan-wrapped upconversion nanoparticle for targeted near-infrared photodynamic therapy. Mol. Pharm. 9 (2012), 1580–1589.
112. [112] Eruslanov, E., Kusmartsev, S., Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol. 594 (2010), 57–72.
113. [113] Sivanandham, V., Free radicals in health and diseases. PharmacologyOnLine (PhOl) 1 (2011), 1062–1077.
114. [114] Panzarini, E., Inguscio, V., Fimia, G.M., Dini, L., Rose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of damage-associated molecular patterns (DAMPs) in human HeLa cells. PLoS One, 9(8), 2014, e105778.
115. [115] Thompson, A., Canella, Karen A., Lever, John R., Miura, Kyo, Posner, Gary H., Seliger, Howard H., Chemiluminescence mechanism and quantum yield of synthetic vinylpyrene analogs of benzo[a]pyrene-7, 8-dihydrodiol. J. Am. Chem. Soc. 108:15 (1986), 4498–4504.
116. [116] Shapiro, H.M., Membrane potential estimation by flow cytometry. Methods 21 (2000), 271–279.
117. [117] Bene, L., Oxonol has the potential to probe membrane fields. Cytometry 83A (2013), 608–611.
118. [118] Depince-Berger, A.E., Aanei, C., Iobagiu, C., Jeraiby, M., Lambert, C., New tools in cytometry. Morphologie 100:331 (2016), 199–209.
119. [119] Jones AP, A.P., Kermode, A.G., Lucas, R.M., Carroll, W.M., Nolan, D., Hart, P.H., Circulating immune cells in multiple sclerosis. Clin. Exp. Immunol. Sep., 30, 2016, 10.1111/cei.12878.
120. [120] Claes, N., Dhaeze, T., Fraussen, J., Broux, B., Van Wijmeersch, B., Stinissen, P., Hupperts, R., Hellings, N., Somers, V., Compositional changes of B and T cell subtypes during fingolimod treatment in multiple sclerosis patients: a 12-month follow-up study. PLoS One, 9(10), 2014, e111115.
121. [121] Mitosek-Szewczyk, K., Tabarkiewicz, J., Wilczynska, B., Lobejko, K., Berbecki, J., Nastaj, M., Dworzanska, E., Kolodziejczyk, B., Stelmasiak, Z., Rolinski, J., Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis. J. Neurol. Sci. 332:1–2 (2013), 35–40.
122. [122] Martin, R., Sospedra, M., Rosito, M., Engelhardt, B., Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis. Eur. J. Immunol. 46:9 (2016), 2078–2090.
123. [123] Minchinton, A.I., Tannock, I.F., Drug penetration in solid tumours. Nat. Rev. Cancer 6 (2006), 583–592.
124. [124] McFarlin, B.K., Gary, M.A., Flow cytometry what you see matters: enhanced clinical detection using image-based flow cytometry. Methods(16), 2016, S1046–S2023, 10.1016/j.ymeth.2016.09.001 (30296-1).
125. [125] Haridas, V., Ranjbar, S., Vorobjev, I.A., Goldfeld, A.E., Barteneva, N.S., Imaging flow cytometry analysis of intracellular pathogens. Methods, 2016, 10.1016/j.ymeth.2016.09.007.
126. [126] Manickam, P., Kaushik, A., Karunakaran, C., Bhansali, S., Recent advances in cytochrome c biosensing technologies. Biosens. Bioelectron. 87 (2016), 654–668.
127. [127] Barteneva, N.S., Fasler-Kan, E., Vorobjev, I.A., Imaging flow cytometry coping with heterogeneity in biological systems. J. Histochem. Cytochem. 60:10 (2012), 723–733.